Belgium· BE-AMP-SAM067837-00
Daonil 5 mg
A metahexamid product containing glibenclamide, registered in Belgium by Sanofi Belgium.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Glibenclamide
- Manufacturer
- Sanofi Belgium
- Country
- Belgium (BE)
- ATC code
- A10BB10
- ATC class
- Metahexamid
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0033316
- be_apb0704106
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Metahexamid in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesglyburideZydus Pharmaceuticals (USA) Inc.
- United KingdomAmglidia 0.6mg/ml oral suspension with 1ml oral syringeBioprojet UK Ltd
- FranceAMGLIDIA 0,6 mg/mL, suspension buvableAMMTEK
- FinlandAMGLIDIAAMMTek
- CanadaAPO GLYBURIDE TAB 2.5MGAPOTEX INC
- NorwayGlib-ratiopharm SRatiopharm
- CzechiaAMGLIDIAAMMTeK, Paris
- SpainAMGLIDIA 0,6 mg/ml SUSPENSION ORALAmmtek
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Cyprus · Glibesyn, Glitisol
- Germany · Glib-Ratiopharm S, Glibenclamid Abz
- Spain · Glucolón
- France · Daonil, Glibenclamide Arrow
- United Kingdom (Northern Ireland) · Glibenclamide Activase Pharmaceuticals, Glibenclamide Ennogen Ip
- Greece · Asugrin, Deroctyl
- Iceland · Amglidia
- Italy · Gliben, Gliboral
- Liechtenstein · Amglidia
- Malta · Glitisol
- Norway · Amglidia
- Portugal · Glibenclamida Generis
- Romania · Glibenclamidă Arena
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cc0eeece-0a98-493e-bb06-4464ee2e9e4b GET /v1/drugs/cc0eeece-0a98-493e-bb06-4464ee2e9e4b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Daonil 5 mg",
"name_fr": "Daonil 5 mg",
"name_nl": "Daonil 5 mg",
"amp_code": "SAM067837-00",
"strengths": [
"5.0000",
"5.0000",
"79.0000"
],
"pack_count": 2,
"substances": [
"Glibenclamide",
"Lactose Monohydrate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Metahexamide",
"authorisation_numbers": [
"BE067837"
]
}See everything about metahexamid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.